AMRZ Form 4: James Gosa granted 55,639 RSUs under 2025 Omnibus Plan

Rhea-AI Filing Summary

James J. Gosa, who is identified as an officer (President, Building Envelope) and a director of Amrize Ltd (AMRZ), was awarded restricted stock units on 08/11/2025 under the Amrize Ltd 2025 Omnibus Incentive Plan. Two awards were reported: 36,952 RSUs that vest on March 21, 2026 and 18,687 RSUs that vest on March 21, 2027. Both grants are recorded with a price of $0.

Following these reported transactions the filing shows the reporting person beneficially owns 55,639 ordinary shares on a direct basis. The entries are presented as non-derivative security acquisitions (restricted stock unit awards) with the vesting schedule and award source explicitly stated in the explanations.

Positive

• Grant of 55,639 RSUs to the reporting person is explicitly documented (36,952 and 18,687 units).
• Clear vesting schedule is provided: vesting on March 21, 2026 and March 21, 2027.

Negative

• Grants recorded at $0, indicating no cash consideration in the transactions as reported.
• Filing does not disclose outstanding share count or percentage dilution, so ownership impact relative to total shares is unspecified.

Insights

Corporate Governance Expert

TL;DR: Officer-director received time‑based RSU awards totaling 55,639 shares with two distinct vesting dates, disclosed under the 2025 Omnibus Plan.

The Form 4 discloses typical equity-based compensation rather than a sale or transfer. The awards are structured as restricted stock units granted at $0 that vest in two installments on March 21, 2026 and March 21, 2027. As disclosed, these are direct beneficial holdings after the grants. This is a routine disclosure for insider compensation; the filing provides clear dates, amounts, and plan reference but no information on the aggregate dilution relative to outstanding shares or performance conditions beyond vesting dates.

Securities Analyst

TL;DR: Insider acquired 55,639 shares via RSUs on 08/11/2025; awards vest over two years and are recorded as non‑derivative acquisitions.

The transaction entries report two restricted stock unit awards totaling 55,639 ordinary shares granted under the 2025 Omnibus Incentive Plan and recorded with a $0 price. The filing lists direct beneficial ownership following the transactions as 55,639 shares. There are no derivative instruments, no cash proceeds, and no exercises or sales reported. The disclosure is concise and focused on grant mechanics and vesting schedule; market impact cannot be assessed from the filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gosa James J

(Last) (First) (Middle)

GRAFENAUWEG 8

(Street)

ZUG V8 6300

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Building Envelope

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2025		A		36,952(1)	A	$0	36,952	D
Ordinary Shares	08/11/2025		A		18,687(2)	A	$0	55,639	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on March 21, 2026.

2. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on March 21, 2027.

	Hans Weinburger, Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Amrize (AMRZ) Form 4 report about insider James J. Gosa?

The Form 4 reports that James J. Gosa was awarded restricted stock units totaling 55,639 ordinary shares on 08/11/2025 under the Amrize Ltd 2025 Omnibus Incentive Plan.

How many RSUs were granted and when do they vest for AMRZ insider filings?

Two RSU grants were reported: 36,952 units vesting on March 21, 2026 and 18,687 units vesting on March 21, 2027.

Does the Form 4 show any cash proceeds from the transactions for AMRZ?

No cash proceeds are reported; both awards are recorded with a $0 price in the filing.

What is the reporting person’s beneficial ownership after the reported transactions?

The filing reports the reporting person’s direct beneficial ownership following the transactions as 55,639 ordinary shares.

Were any derivative securities reported in this AMRZ Form 4?

No. Table II for derivative securities contains no entries; only non‑derivative restricted stock unit awards are reported.